Bayer Group's number of employees 2009-2023

Bayer is an international pharmaceutical company based out of Germany. As of end-2023, the company had a total of just under 100,000 employees globally. This is a significant lower figure when compared to 2018 and 2019. In general, the number of employees at Bayer had remained stable until 2016 when Convestro, Bayer’s Material Science division, spun off into its own company. It increased again with the acquisition of Monsanto during 2018.

Bayer’s company profile

Bayer works in about three segments globally: pharmaceuticals, consumer health, and crop science. In August 2019, Bayer agreed to sell its animal health division to Elanco. Bayer’s yearly revenues have been variable in recent years but have still show significant growth since the 1990s. Most recently Bayer’s pharmaceutical and crop science segments have generated the most revenue for the company. Among Bayer’s pharmaceutical segment the top pharmaceutical product is Xarelto, a blood thinning agent used in the treatment of blood clots.

Bayer’s global positioning

As of 2022, Bayer was among the top pharmaceutical companies in many regards. Bayer ranks as 17th among the top 50 global pharmaceutical companies based on the sales of their prescription drugs. Bayer was also ranked as the sixth most valuable pharmaceutical brand in recent years. Other major pharmaceutical companies such as Roche, Pfizer, and AbbVie were listed among the most valuable pharmaceutical brands during that same year.